Live Attenuated and Sub-Unit Vaccines Exploitation Against Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-COV2]

Live Attenuated and Sub-Unit Vaccines Exploitation Against Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-COV2]

Background: Severe acute respiratory syndrome coronavirus 2 [SARS-COV2] is a serious infection nowadays. Infection is typically limited to the mucosal cells of the respiratory tract. At least 50% of infections are asymptomatic. Immunity is brief and reinfection occurs.Aim of the work: Live attenuate...

Full description

Bibliographic Details
Main Author:	Mohammed Kassab
Format:	Article
Language:	English
Published:	Al-Azhar University, Faculty of Medicine (Damietta) 2023-04-01
Series:	International Journal of Medical Arts
Subjects:	vaccine severe acute respiratory syndrome pneumonia droplets
Online Access:	https://ijma.journals.ekb.eg/article_302854_bc53847ccc91f0619a94102827ef7d20.pdf

Similar Items

Severe Acute Respiratory Syndrome (SARS): The traveller's dilemma
by: Gboyegu A. Ogunbanjo
Published: (2003-03-01)

Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by Mass Spectrometry
by: Petra Wandernoth, et al.
Published: (2020-08-01)

EPIDEMICS OF SEVERE ACUTE RESPIRATORY SYNDROME (SARS) IN THE WORLD (REVIEW)
by: G. G. Onishchenko, et al.
Published: (2020-04-01)

Imaging Progression Under Low Respiratory Viral Load of SARS-CoV-2 Omicron Variant Infection: A Retrospective Study in China
by: Li Q, et al.
Published: (2023-10-01)

Comparison of Computed Tomography and Clinical Features Between Patients Infected with the SARS‐CoV‐2 Omicron Variant and the Original Strain
by: Zhang Y, et al.
Published: (2024-03-01)

Characterization of QuantiFERON Severe Acute Respiratory Syndrome Coronavirus 2 and Anti-severe Acute Respiratory Syndrome Coronavirus 2 Nucleocapsid and S1 Spike Protein Antibodies in Vaccinated and Unvaccinated Coronavirus Disease 2019 Patients
by: Esmaeil Mortaz, et al.
Published: (2024-09-01)

Evolutionary dynamics of the severe acute respiratory syndrome coronavirus 2 genomes
by: Qian Zhaohui, et al.
Published: (2022-02-01)

Clinicoepidemiological Profile and Diagnosis of Severe Acute Respiratory Syndrome Coronavirus-2 and Influenza Viruses in Patients with Severe Acute Respiratory Illness by Real-time Reverse Transcription Polymerase Chain Reaction: A Cross-sectional Study
by: Maasha, et al.
Published: (2023-10-01)

SARS-CoV-2 Infection with Different Radiological Insights
by: Barbara Brogna, et al.
Published: (2020-05-01)

Hearing profile of recovered severe acute respiratory syndrome Coronavirus-2 (SARS-COV2) patients
by: Abdulrahman Nabil Fathi Abdulghffar, et al.
Published: (2023-11-01)

THE FIRST SEVERE ACUTE RESPIRATORY SYNDROME CASE IN RUSSIA
by: A. V. Tarasov, et al.
Published: (2020-04-01)

Effect of the number of coronavirus disease 2019 (COVID-19) vaccination shots on the occurrence of pneumonia, severe pneumonia, and death in SARS-CoV-2-infected patients
by: Shijun Xin, et al.
Published: (2024-01-01)

Sequential Infection with Influenza A Virus Followed by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Leads to More Severe Disease and Encephalitis in a Mouse Model of COVID-19
by: Jordan J. Clark, et al.
Published: (2024-05-01)

Rapid antigen detection of severe acute respiratory syndrome coronavirus-2 in stray cats: A cross-sectional study
by: Ronaldy Santana Santos, et al.
Published: (2024-07-01)

Prenatal transmission of severe acute respiratory syndrome coronavirus 2, resulting in neonatal severe acute pneumonia, from an asymptomatic mother: a case report
by: Narcisse Elenga, et al.
Published: (2023-09-01)

Concurrent Infection with SARS-CoV-2 and <i>Pneumocystis jirovecii</i> in Immunocompromised and Immunocompetent Individuals
by: Francesca Gioia, et al.
Published: (2022-05-01)

SARS-CoV-2 and Other Coronaviruses in Rats, Berlin, Germany, 2023
by: Kerstin Wernike, et al.
Published: (2024-10-01)

Molecular characterization of human adenovirus associated with pediatric severe acute respiratory infections in a tertiary care hospital in North East India
by: Reema Nath, et al.
Published: (2024-10-01)

Inter-host genetic variability of severe acute respiratory syndrome Coronavirus 2 and its implication in biomedicine: A bioinformatics approach
by: Victor Eduardo Rojas-Pérez, et al.
Published: (2023-01-01)

Aprotinin Inhibits SARS-CoV-2 Replication
by: Denisa Bojkova, et al.
Published: (2020-10-01)

SARS war : Combating the Disease /
by: Leung, Ping-Chung, 1941-, et al.
Published: (c200)

PRIMORSKIJ TERRITORIAL ADMINISTRATION HEALTH DEPARTMENT WORK ORGANIZING TO PREVENT SPREADING OF SEVERE ACUTE RESPIRATORY SYNDROME
by: V. G. Ushakov, et al.
Published: (2020-04-01)

SARS-CoV-2 epidemic and blood safety
by: Yongshui FU
Published: (2022-01-01)

Comparing adults with severe SARS-CoV-2 or influenza infection: South Africa, 2016–2021
by: Fiona Els, et al.
Published: (2024-07-01)

Severe Acute Respiratory Syndrome Coronavirus 2 and Respiratory Virus Sentinel Surveillance, California, USA, May 10, 2020–June 12, 2021
by: Gail L. Sondermeyer Cooksey, et al.
Published: (2022-01-01)

Self-Collected versus Healthcare Worker-Collected Swabs in the Diagnosis of Severe Acute Respiratory Syndrome Coronavirus 2
by: Johan H. Therchilsen, et al.
Published: (2020-09-01)

Development of Macrobrachium rosenbergii nodavirus virus-like particles-based Japanese encephalitis virus and severe acute respiratory syndrome coronavirus-2 vaccines
by: Karunanithi, Kiven Kumar
Published: (2022)

Pushing past the tipping points in containment trajectories of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemics: A simple arithmetic rationale for crushing the curve instead of merely flattening it
by: Gerry F. Killeen
Published: (2020-01-01)

ABOUT THE LABORATORY DIAGNOSTICS OF SEVERE ACUTE RESPIRATORY SYNDROME AT PRIMORSKIJ TERRITORY
by: A. V. Allenov, et al.
Published: (2020-04-01)

Viral Shedding among Re-Positive Severe Acute Respiratory Syndrome Coronavirus-2 Positive Individuals in Republic of Korea
by: Jeong-Min Kim, et al.
Published: (2021-10-01)

Angiotensin-Converting Enzyme 2 (ACE2) in the Context of Respiratory Diseases and Its Importance in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
by: Enrique Ambrocio-Ortiz, et al.
Published: (2021-08-01)

Membrane cholesterol modulates oligomeric status and peptide-membrane interaction of severe acute respiratory syndrome coronavirus fusion peptide
by: Meher, Geetanjali, et al.
Published: (2022)

Process Failures That Increase the Risk of Infection Through Respiratory Droplets: A Study of Patient Safety Events Reported by Hospitals Across Pennsylvania
by: Amy Harper, et al.
Published: (2020-09-01)

<em>Scutellaria barbata</em> D. Don Inhibits the Main Proteases (M<sup>pro</sup> and TMPRSS2) of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
by: Sheng-Teng Huang, et al.
Published: (2021-05-01)

SARS-CoV-2 RNA Shedding in Semen and Oligozoospermia of Patient with Severe Coronavirus Disease 11 Weeks after Infection
by: Lawrence J. Purpura, et al.
Published: (2022-01-01)

Cold chain and severe acute respiratory syndrome coronavirus 2 transmission: a review for challenges and coping strategies
by: Liu Jiangtao, et al.
Published: (2022-02-01)

Skeletal Muscles of Patients Infected with SARS-CoV-2 Develop Severe Myofiber Damage upon One Week of Admission on the Intensive Care Unit
by: Sjoerd Stevens, et al.
Published: (2022-07-01)

CircRNAs in BALF exosomes and plasma as diagnostic biomarkers in patients with acute respiratory distress syndrome caused by severe pneumonia
by: He Sun, et al.
Published: (2023-08-01)

Systematic Genomic and Clinical Analysis of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfections and Recurrences Involving the Same Strain
by: Cristina Rodríguez-Grande, et al.
Published: (2022-01-01)

Susceptibility of Domestic Goat (<i>Capra aegagrus hircus</i>) to Experimental Infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) B.1.351/Beta Variant
by: Leira Fernández-Bastit, et al.
Published: (2022-09-01)